(HealthDay)—NBA great Michael Jordan had a special ritual he would follow before every free throw: He would assume a shoulder-width stance, spin the basketball in his hands, bounce the ball three times, and then spin the ...
Nov 29, 2021
0
2
Results from a Phase II trial led by researchers at The University of Texas MD Anderson Cancer Center showed that treatment with belzutifan, a small-molecule inhibitor of hypoxia-inducible factor (HIF)-2a, achieved strong ...
Nov 24, 2021
0
21
More people with advanced melanoma survive for two years or more when they receive a combination of two immunotherapy drugs given before a combination of two targeted therapies, if needed, compared to people who start treatment ...
Nov 15, 2021
0
10
New UBC research suggests free-roaming cats are likely to blame in the spread of the potentially deadly Toxoplasma gondii parasite to wildlife in densely populated urban areas.
Nov 10, 2021
0
6
Regular blood tests before and during chemotherapy for prostate cancer can detect whether or not a patient is resistant or developing resistance to treatment with docetaxel, according to research presented at the NCRI Festival.
Nov 10, 2021
0
1
Cervical cancer cases plummeted among British women who received a vaccination against the human papillomavirus, according to a study published Thursday.
Nov 4, 2021
0
49
Even though young patients with metastatic colorectal cancer tend to be more fit and receive more intensive treatment than older patients, both groups survive for roughly the same amount of time, according to a new study ...
Oct 27, 2021
0
29
A review by the GLUTEN3S research group at the UPV/EHU-University of the Basque Country describes the nutritional imbalances found in adults suffering from celiac disease who follow a gluten-free diet. The keys to avoiding ...
Sep 27, 2021
0
5
The first randomized study in malignant pheochromocytoma and paraganglioma (MPP) has found that sunitinib prolongs progression-free survival (PFS) by more than five months. The late breaking results of the FIRSTMAPPP trial ...
Sep 20, 2021
0
15
A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center has found that treating women with HER2 positive metastatic breast cancer with the HER2-targeting antibody-drug conjugate trastuzumab deruxtecan (T-DXd) ...
Sep 18, 2021
0
58
